Techcrunch: "TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials"

Clinical trials have a data problem. Techcrunch covered how we're solving it:

"The specific problem that TrialReach’s platform aims to tackle is that many clinical trials go unfulfilled, rendering them worthless, or are significantly delayed, simply because not enough patients can be signed up. This is partly an awareness problem — many patients who have exhausted existing treatments don’t know that clinical trials are an option — but is also a data problem.

That’s because clinical trials are defined in a document called ‘protocol’, a scientific paper typically over 100 pages long, which isn’t intended to be read by patients, but is written for physicians and healthcare regulators.

Meanwhile, the part relating to which patients might qualify for the trial — the inclusion/exclusion criteria — consists of free-form text, meaning that there’s no simple way to quickly (and automatically) use that data to match patients with trials.

To solve this, TrialReach’s platform is designed to aggregate and, crucially, structure clinical trial listings data, making it ‘machine readable’, so that patients can be “smart matched” with specific trials that are relevant to their condition and to which they may actually qualify."

Read more at TechCrunch.